Interleukin-24 as a Pulmonary Target Cytokine in Bronchopulmonary Dysplasia
- 8 March 2021
- journal article
- research article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 79 (2) , 311-320
Abstract
The proliferation of fetal alveolar type II cells (FATIICs) was impaired in bronchopulmonary dysplasia (BPD), which is modulated by hyperoxia and inflammatory response. Interleukin 24 (IL-24), a cytokine produced by certain cell types, plays an essential role in inflammation and host protection against infection. However, the ability of FATIICs to produce IL-24 remains unclear, and the role of IL-24 in BPD progression is yet to be determined. With reverse transcription quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay, the authors evaluated whether FATIICs produce IL-24 in physiological conditions. The authors quantified IL-24 expression in the lungs of newborn rat pups exposed to hyperoxia (70% oxygen) and in FATIICs isolated on embryonic day 19 that were exposed to 95% oxygen or lipopolysaccharide (LPS). The role of IL-24 in FATIICs, cell proliferation, cell apoptosis, and cell cycle were further evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and flow cytometric analysis. Also, they assessed caspase-3 and SOCS3 mRNA in IL-24 siRNA-treated cells by using RT-qPCR. During culture, IL-24 mRNA and protein levels in FATIICs gradually decreased with FATIIC differentiation. IL-24 expression increased significantly in rat lungs exposed to hyperoxia and FATIICs exposed to oxygen or LPS. Recombinant IL-24 enhanced cell proliferation by decreasing the proportion of apoptotic cells and increasing the proportion of cells in the S phase. The IL-24 siRNA-treated cells expressed more caspase-3 mRNA. Furthermore, suppressor of cytokine signaling 3 (SOCS3) mRNA was significantly decreased in rats and FATIICs exposed to oxygen, whereas it dramatically increased in FATIICs exposed to LPS. The IL-24 siRNA-treated cells expressed more SOCS3 mRNA. These studies suggest IL-24 is a pulmonary target cytokine in BPD, and may possibly regulate SOCS3 in oxidative stress and inflammation of the lung.Keywords
Funding Information
- key scientific and technological project of the Chinese Ministry of Education (212103)
This publication has 42 references indexed in Scilit:
- Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressNature Medicine, 2014
- Neonatal Hyperoxia Stimulates the Expansion of Alveolar Epithelial Type II CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- Suppression effect of recombinant adenovirus vector containing hIL-24 on Hep-2 laryngeal carcinoma cellsOncology Letters, 2014
- Effect of Hyperoxia on the Viability and Proliferation of the Primary Type II Alveolar Epithelial CellsCell Biochemistry and Biophysics, 2013
- Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposureJournal of Applied Physiology, 2010
- IL-24 Transgenic Mice: In Vivo Evidence of Overlapping Functions for IL-20, IL-22, and IL-24 in the EpidermisThe Journal of Immunology, 2010
- Placental IL-10 Dysregulation and Association With Bronchopulmonary Dysplasia RiskPediatric Research, 2009
- Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel DiseaseThe Journal of Immunology, 2009
- IL-24 is Expressed by Rat and Human MacrophagesImmunobiology, 2002